Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Chongqing Peg-Bio Biopharm Co., Ltd.
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Heart, Lung, and Blood Institute (NHLBI)
Memorial Sloan Kettering Cancer Center
Boston Children's Hospital
Center for International Blood and Marrow Transplant Research
Centre Henri Becquerel
Murdoch Childrens Research Institute
Fayoum University
Thomas Jefferson University
Dartmouth-Hitchcock Medical Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
University Hospital, Grenoble
Centre Hospitalier Universitaire de Liege
Duke University
Beijing Suncadia Pharmaceuticals Co., Ltd
Fadoi Foundation, Italy
Kazakh Institute of Oncology and Radiology
Thomas Jefferson University
Rigshospitalet, Denmark
University of Aberdeen
Fred Hutchinson Cancer Center
University of Utah
LEO Pharma
Centre Hospitalier Annecy Genevois
AstraZeneca
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University Hospital, Angers
Radboud University Medical Center
Radboud University Medical Center
Advice Pharma Group srl
Bayer
Ottawa Hospital Research Institute
Centre Leon Berard
Chongqing University Cancer Hospital
Assistance Publique - Hôpitaux de Paris
National Institutes of Health Clinical Center (CC)
Ottawa Hospital Research Institute
University of Aarhus
Duke University
National Cancer Institute (NCI)
Westat
Kyowa Kirin Co., Ltd.
Radboud University Medical Center
National Cancer Institute (NCI)